这些儿童被随机予依那西普或安慰剂组。
The children were randomized to either etanercept or placebo.
给予糖尿病小鼠静脉、鞘内或足底注射依那西普。
Etanercept was given by either intravenous (i. v. ), intrathecal (i. th. ) or intraplantar (i. pl. ) routes to the diabetic mice.
如果发生明显的血液恶液质，依那西普应当被停用。
Etanercept should be discontinued if a blood dyscrasia is evident.
目的评价依那西普治疗强直性脊柱炎的效果和安全性。
Objective To evaluate the efficacy and safety of etanercept in treatment of ankylosing spondylitis.
英利昔单抗和依那西普分别使用与患淋巴瘤风险间也无相关关系。
Infliximab and etanercept considered individually also were not associated with a risk of lymphoma.
分别给患者安慰剂和依那西普，一种可以阻断毒性细胞因子作用的复合物。
Patients were either given a placebo or etanercept, a compound which blocks the effects of toxic cytokines.
研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显著增高。
Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept.
依那西普是一个重组可溶性肿瘤坏死因子- α受体融合蛋白，它可结合肿瘤坏死因子- α 。
Etanercept is a recombinant soluble TNF-alpha receptor fusion protein that binds to TNF-alpha.
国际肝病：最近在胃肠病学杂志上发表了酒精性肝炎使用依那西普的临床试验结果，您是作者之一。
Hepatology Digest: Recently, the clinical trial result for the use of Etanercept for alcoholic hepatitis was published in Gastroenterology, and you were one of the authors.
阿达木单抗、依那西普和依那西普与安慰剂相对比，可以看到至少增加40%以上症状改善的病人。
For adalimumab, etanercept and rituximab, an increase of at least 40% was seen in the number of people experiencing improved symptoms, when the drugs were compared to placebos.
梅奥诊所的一项新的研究发现依那西普药物治疗酒精性肝炎，一种酒精过量导致的急性肝脏炎性改变是无效的。
A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol.
从基准到第24周C -肽曲线下面积依那西普组表现出较大变化（ 依那西普组增加39 ％与安慰剂组下降20 ％；
The etanercept group showed a greater percent change in C-peptide area under the curve from baseline to week 24 (39% increase in etanercept group versus 20% decrease in placebo group;
从基准到第24周C -肽曲线下面积依那西普组表现出较大变化（ 依那西普组增加39 ％与安慰剂组下降20 ％；
The etanercept group showed a greater percent change in C-peptide area under the curve from baseline to week 24 (39% increase in etanercept group versus 20% decrease in placebo group;
应用推荐